Human beta-defensin-3 promotes wound healing in infected diabetic wounds

Tobias Hirsch, Malte Spielmann, Baraa Zuhaili, Magdalena Fossum, Marie Metzig, Till Koehler, Hans Ulrich Steinau, Feng Yao, Andrew Bruce Onderdonk, Lars Steinstraesser, Elof Eriksson

Research output: Contribution to journalArticle

Abstract

Background: Infected wounds present a major complication in patients with diabetes. Staphylococcus aureus is the most common single isolate in diabetic wounds. Human beta-defensin (hBD)-3 is antimicrobial active and appears to play a key role in the immune response. The present study aimed to analyse the effect of hBD-3 expression in a model of infected diabetic wounds. Methods: Excisional wounds were created on the backs of Yorkshire pigs and Ad5-CMV-hBD-3 vectors were microseeded. Wounds were inoculated with S. aureus, covered with a polyurethane chamber and analysed for transgene expression, bacterial infection, re-epithelialization, wound contraction, wound fluid production and blood vessel formation. Results: hBD-3-treated wounds showed a total bacterial load of 2.1 × 108 colony-forming units (CFU)/g tissue, versus 1.3 × 109 CFU/g tissue for controls (p < 0.001) at day 4. At day 12, no statistical difference could be detected. Re-epithelialization showed 75 ± 15% wound closure for hBD-3 expressing wounds and 50 ± 16% for controls (p < 0.01). hBD-3 expression was in the range 15-20 ng/ml of wound fluid during day 1-4. The lower dose of 2 × 109 Ad5-CMV-hBD-3 showed no effect, suggesting a dose dependency for hBD-3. Conclusions: In the present study, we show that hBD-3 expression significantly promotes wound closure in S. aureus infected diabetic wounds in a preclinical large-animal model. Furthermore, a ten-fold reduction of bacterial growth on day 4 was detected. These findings indicate that beta-defensin-3 may play a major role in diabetic wound healing and wound infections.

Original languageEnglish (US)
Pages (from-to)220-228
Number of pages9
JournalJournal of Gene Medicine
Volume11
Issue number3
DOIs
StatePublished - May 29 2009
Externally publishedYes

Fingerprint

Wound Healing
Wounds and Injuries
Re-Epithelialization
Staphylococcus aureus
human beta-defensin 3
Stem Cells
beta-Defensins
Polyurethanes
Bacterial Load
Wound Infection
Transgenes
Bacterial Infections
Blood Vessels
Swine
Animal Models

Keywords

  • Bacterial infection
  • Gene transfer
  • Host defense peptides
  • Innate immunity
  • S. aureus
  • Wound healing

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Drug Discovery
  • Genetics(clinical)

Cite this

Hirsch, T., Spielmann, M., Zuhaili, B., Fossum, M., Metzig, M., Koehler, T., ... Eriksson, E. (2009). Human beta-defensin-3 promotes wound healing in infected diabetic wounds. Journal of Gene Medicine, 11(3), 220-228. https://doi.org/10.1002/jgm.1287

Human beta-defensin-3 promotes wound healing in infected diabetic wounds. / Hirsch, Tobias; Spielmann, Malte; Zuhaili, Baraa; Fossum, Magdalena; Metzig, Marie; Koehler, Till; Steinau, Hans Ulrich; Yao, Feng; Onderdonk, Andrew Bruce; Steinstraesser, Lars; Eriksson, Elof.

In: Journal of Gene Medicine, Vol. 11, No. 3, 29.05.2009, p. 220-228.

Research output: Contribution to journalArticle

Hirsch, T, Spielmann, M, Zuhaili, B, Fossum, M, Metzig, M, Koehler, T, Steinau, HU, Yao, F, Onderdonk, AB, Steinstraesser, L & Eriksson, E 2009, 'Human beta-defensin-3 promotes wound healing in infected diabetic wounds', Journal of Gene Medicine, vol. 11, no. 3, pp. 220-228. https://doi.org/10.1002/jgm.1287
Hirsch, Tobias ; Spielmann, Malte ; Zuhaili, Baraa ; Fossum, Magdalena ; Metzig, Marie ; Koehler, Till ; Steinau, Hans Ulrich ; Yao, Feng ; Onderdonk, Andrew Bruce ; Steinstraesser, Lars ; Eriksson, Elof. / Human beta-defensin-3 promotes wound healing in infected diabetic wounds. In: Journal of Gene Medicine. 2009 ; Vol. 11, No. 3. pp. 220-228.
@article{84b41215b36f4cd2a785202561dd7345,
title = "Human beta-defensin-3 promotes wound healing in infected diabetic wounds",
abstract = "Background: Infected wounds present a major complication in patients with diabetes. Staphylococcus aureus is the most common single isolate in diabetic wounds. Human beta-defensin (hBD)-3 is antimicrobial active and appears to play a key role in the immune response. The present study aimed to analyse the effect of hBD-3 expression in a model of infected diabetic wounds. Methods: Excisional wounds were created on the backs of Yorkshire pigs and Ad5-CMV-hBD-3 vectors were microseeded. Wounds were inoculated with S. aureus, covered with a polyurethane chamber and analysed for transgene expression, bacterial infection, re-epithelialization, wound contraction, wound fluid production and blood vessel formation. Results: hBD-3-treated wounds showed a total bacterial load of 2.1 × 108 colony-forming units (CFU)/g tissue, versus 1.3 × 109 CFU/g tissue for controls (p < 0.001) at day 4. At day 12, no statistical difference could be detected. Re-epithelialization showed 75 ± 15{\%} wound closure for hBD-3 expressing wounds and 50 ± 16{\%} for controls (p < 0.01). hBD-3 expression was in the range 15-20 ng/ml of wound fluid during day 1-4. The lower dose of 2 × 109 Ad5-CMV-hBD-3 showed no effect, suggesting a dose dependency for hBD-3. Conclusions: In the present study, we show that hBD-3 expression significantly promotes wound closure in S. aureus infected diabetic wounds in a preclinical large-animal model. Furthermore, a ten-fold reduction of bacterial growth on day 4 was detected. These findings indicate that beta-defensin-3 may play a major role in diabetic wound healing and wound infections.",
keywords = "Bacterial infection, Gene transfer, Host defense peptides, Innate immunity, S. aureus, Wound healing",
author = "Tobias Hirsch and Malte Spielmann and Baraa Zuhaili and Magdalena Fossum and Marie Metzig and Till Koehler and Steinau, {Hans Ulrich} and Feng Yao and Onderdonk, {Andrew Bruce} and Lars Steinstraesser and Elof Eriksson",
year = "2009",
month = "5",
day = "29",
doi = "10.1002/jgm.1287",
language = "English (US)",
volume = "11",
pages = "220--228",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Human beta-defensin-3 promotes wound healing in infected diabetic wounds

AU - Hirsch, Tobias

AU - Spielmann, Malte

AU - Zuhaili, Baraa

AU - Fossum, Magdalena

AU - Metzig, Marie

AU - Koehler, Till

AU - Steinau, Hans Ulrich

AU - Yao, Feng

AU - Onderdonk, Andrew Bruce

AU - Steinstraesser, Lars

AU - Eriksson, Elof

PY - 2009/5/29

Y1 - 2009/5/29

N2 - Background: Infected wounds present a major complication in patients with diabetes. Staphylococcus aureus is the most common single isolate in diabetic wounds. Human beta-defensin (hBD)-3 is antimicrobial active and appears to play a key role in the immune response. The present study aimed to analyse the effect of hBD-3 expression in a model of infected diabetic wounds. Methods: Excisional wounds were created on the backs of Yorkshire pigs and Ad5-CMV-hBD-3 vectors were microseeded. Wounds were inoculated with S. aureus, covered with a polyurethane chamber and analysed for transgene expression, bacterial infection, re-epithelialization, wound contraction, wound fluid production and blood vessel formation. Results: hBD-3-treated wounds showed a total bacterial load of 2.1 × 108 colony-forming units (CFU)/g tissue, versus 1.3 × 109 CFU/g tissue for controls (p < 0.001) at day 4. At day 12, no statistical difference could be detected. Re-epithelialization showed 75 ± 15% wound closure for hBD-3 expressing wounds and 50 ± 16% for controls (p < 0.01). hBD-3 expression was in the range 15-20 ng/ml of wound fluid during day 1-4. The lower dose of 2 × 109 Ad5-CMV-hBD-3 showed no effect, suggesting a dose dependency for hBD-3. Conclusions: In the present study, we show that hBD-3 expression significantly promotes wound closure in S. aureus infected diabetic wounds in a preclinical large-animal model. Furthermore, a ten-fold reduction of bacterial growth on day 4 was detected. These findings indicate that beta-defensin-3 may play a major role in diabetic wound healing and wound infections.

AB - Background: Infected wounds present a major complication in patients with diabetes. Staphylococcus aureus is the most common single isolate in diabetic wounds. Human beta-defensin (hBD)-3 is antimicrobial active and appears to play a key role in the immune response. The present study aimed to analyse the effect of hBD-3 expression in a model of infected diabetic wounds. Methods: Excisional wounds were created on the backs of Yorkshire pigs and Ad5-CMV-hBD-3 vectors were microseeded. Wounds were inoculated with S. aureus, covered with a polyurethane chamber and analysed for transgene expression, bacterial infection, re-epithelialization, wound contraction, wound fluid production and blood vessel formation. Results: hBD-3-treated wounds showed a total bacterial load of 2.1 × 108 colony-forming units (CFU)/g tissue, versus 1.3 × 109 CFU/g tissue for controls (p < 0.001) at day 4. At day 12, no statistical difference could be detected. Re-epithelialization showed 75 ± 15% wound closure for hBD-3 expressing wounds and 50 ± 16% for controls (p < 0.01). hBD-3 expression was in the range 15-20 ng/ml of wound fluid during day 1-4. The lower dose of 2 × 109 Ad5-CMV-hBD-3 showed no effect, suggesting a dose dependency for hBD-3. Conclusions: In the present study, we show that hBD-3 expression significantly promotes wound closure in S. aureus infected diabetic wounds in a preclinical large-animal model. Furthermore, a ten-fold reduction of bacterial growth on day 4 was detected. These findings indicate that beta-defensin-3 may play a major role in diabetic wound healing and wound infections.

KW - Bacterial infection

KW - Gene transfer

KW - Host defense peptides

KW - Innate immunity

KW - S. aureus

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=65349178179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349178179&partnerID=8YFLogxK

U2 - 10.1002/jgm.1287

DO - 10.1002/jgm.1287

M3 - Article

C2 - 19115333

AN - SCOPUS:65349178179

VL - 11

SP - 220

EP - 228

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 3

ER -